뉴로크린 바이오사이언시스 (NBIX)

Oct 07, 2025

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results - The AI Journal

Oct 07, 2025

Oct 07, 2025

Q3 2025 Results: Neurocrine Biosciences to Host Oct. 28 Webcast & Call at 1:30 p.m. PT; Replay 1 Month - Stock Titan

Oct 07, 2025

Oct 07, 2025

How New Three-Year INGREZZA Data at Neurocrine Biosciences (NBIX) Has Changed Its Investment Story - simplywall.st

Oct 07, 2025

Oct 07, 2025

A Fresh Look at Neurocrine Biosciences (NBIX) Valuation After Latest INGREZZA Clinical Study Results - Yahoo Finance

Oct 07, 2025

Oct 06, 2025

Earnings call transcript: Neurocrine Q2 2025 shows strong sales growth By Investing.com - Investing.com Australia

Oct 06, 2025

Oct 06, 2025

Neurocrine Biosciences names Mike Sibley to lead neuropsychiatry franchise By Investing.com - Investing.com Nigeria

Oct 06, 2025

Oct 06, 2025

Neurocrine reports sustained benefits of INGREZZA for Huntington’s chorea By Investing.com - Investing.com Nigeria

Oct 06, 2025

Oct 06, 2025

20+ years commercial leader Mike Sibley named Neurocrine SVP & GM, Neuropsychiatry to lead INGREZZA franchise - Stock Titan

Oct 06, 2025

Oct 06, 2025

Earnings call transcript: Neurocrine Q2 2025 shows strong sales growth - Investing.com India

Oct 06, 2025

Oct 06, 2025

Is Neurocrine Biosciences Inc. a candidate for recovery playJuly 2025 Update & Low Drawdown Trading Techniques - newser.com

Oct 06, 2025

Oct 06, 2025

What MACD signals say about Neurocrine Biosciences Inc.Insider Selling & Smart Allocation Stock Tips - newser.com

Oct 06, 2025

Oct 06, 2025

Intraday pattern recognizer results for Neurocrine Biosciences Inc.2025 Market Overview & Daily Price Action Insights - newser.com

Oct 06, 2025

Oct 06, 2025

Neurocrine reports sustained benefits of INGREZZA for Huntington’s chorea - Investing.com

Oct 06, 2025

Oct 06, 2025

Neurocrine shows 3-year safety data for Huntington's drug INGREZZA - StreetInsider

Oct 06, 2025

Oct 06, 2025

Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea - PR Newswire

Oct 06, 2025

Oct 06, 2025

Technical signs of recovery in Neurocrine Biosciences Inc.Weekly Market Report & Risk Controlled Daily Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Will Neurocrine Biosciences Inc. stock deliver consistent dividends2025 Year in Review & Daily Stock Trend Reports - newser.com

Oct 06, 2025

Oct 05, 2025

What the G7 Rare Earths News Means for Neurocrine Biosciences Valuation in 2025 - simplywall.st

Oct 05, 2025

Oct 05, 2025

Will Neurocrine Biosciences Inc. benefit from macro trends2025 Short Interest & Real-Time Volume Triggers - newser.com

Oct 05, 2025

Oct 05, 2025

Will Neurocrine Biosciences Inc. (NB3) stock see valuation expansionEarnings Summary Report & Free Community Consensus Stock Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Why Neurocrine Biosciences Inc. (NB3) stock fits value portfolios2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

What momentum shifts mean for Neurocrine Biosciences Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Is Neurocrine Biosciences Inc. (NB3) stock a buy during volatile marketsFed Meeting & Reliable Price Action Trade Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Why Neurocrine Biosciences Inc. stock is trending among retail traders2025 Market Outlook & Capital Efficient Trade Techniques - newser.com

Oct 05, 2025

Oct 04, 2025

Neurocrine (NBIX) Gets a Buy from Bank of America Securities - The Globe and Mail

Oct 04, 2025

Oct 03, 2025

Neurocrine Biosciences (NBIX): Exploring Valuation After Recent Share Price Movement - simplywall.st

Oct 03, 2025

Oct 03, 2025

Can Neurocrine Biosciences Inc. stock maintain growth trajectoryPortfolio Update Report & Verified Momentum Stock Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Will breakout in Neurocrine Biosciences Inc. lead to full recoveryRate Cut & Safe Entry Point Identification - newser.com

Oct 03, 2025

Oct 03, 2025

Should I buy Neurocrine Biosciences Inc. (NB3) stock before earnings seasonWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Why Neurocrine Biosciences Inc. stock could benefit from AI revolutionCEO Change & Long-Term Safe Investment Plans - newser.com

Oct 03, 2025

Oct 01, 2025

Iambic Therapeutics Announces the Addition of Shalini Sharp to its Board of Directors - Business Wire

Oct 01, 2025